Báez-Suárez, Aníbal
Padrón-Rodríguez, Iraya
Castellano-Moreno, Elizabeth
González-González, Erica
Quintana-Montesdeoca, María P.
Medina-Ramirez, Raquel Irina
Article History
Received: 25 December 2022
Accepted: 12 September 2023
First Online: 15 September 2023
Declarations
:
: This research (ClinicalTrials.gov ID NCT05265702, first registration on 03/03/2022) was approved by the Ethic Committee of the Hospital Complejo Hospitalario Universitario Insular Materno Infantil of Las Palmas de Gran Canaria, Canary Islands, Spain, with the code CEIm- 2022-096-1. It followed the ethical guidelines set out in the Declaration of Helsinki. The participants were informed that they could withdraw from the study whenever they desired without negative consequences. They were also assured confidentiality for their personal information. Informed consent was signed by the parents or legal guardians as the study participants are minors (below 16) before starting the study.
: Not applicable.
: The authors declare no competing interests.